Wegener's granulomatosis: Patient-reported effects of disease on health, function, and income

Arthritis and Rheumatism

Volumn 41, Issue 12, 1998, Pages 2257-2262

  Hoffman, Gary S ^a   Drucker, Yoel ^a   Cotch, Mary Frances ^b   Locker, Geri A ^a,c   Easley, Kirk ^a,c   Kwoh, Kent ^c,d  

^a LERNER RESEARCH INSTITUTE   (United States)

^b NATIONAL EYE INSTITUTE   (United States)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOSUPPRESSIVE AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CHRONIC DISEASE; DISABILITY; FEMALE; HOSPITAL CHARGE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PRIORITY JOURNAL; QUALITY OF LIFE; REMISSION; SOCIOECONOMICS; WEGENER GRANULOMATOSIS;

HEALTH; HUMANS; INCOME; QUALITY OF LIFE; QUESTIONNAIRES; WEGENER GRANULOMATOSIS;

EID: 0032417031     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(199812)41:12<2257::AID-ART22>3.0.CO;2-K     Document Type: Article

References (11)

1. Walton EW. Giant cell granuloma of the respiratory tract (Wegener's granulomatosis). BMJ 1958;2:265-70.
2. Fauci AS, Haynes BF, Katz P, Wolff SM. Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med 1983;98:76-85.
3. Hoffman GS, Kerr GS, Leavitt RY, Hallahan CW, Lebovics RS, Travis WD, et al. Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med 1992;116:488-98.
4. Matteson EL, Gold KN, Bloch DA, Hunder GG. Long-term survival of patients with Wegener's granulomatosis from the American College of Rheumatology Wegener's granulomatosis classification criteria cohort. Am J Med 1996;101:129-34.
5. Leavitt RY, Fauci AS, Bloch DA, Michel BA, Hunder GG, Arend WP, et al. The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum 1990;33:1101-7.
6. Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL, et al. Nomenclature of systemic vasculitides: the proposal of an international consensus conference. Arthritis Rheum 1994;37:187-92.
7. Cotch MF, Hoffman GS, Yerg DE, Kaufman GI, Targonski P, Kaslow RA. The epidemiology of Wegener's granulomatosis: estimates of the five-year period prevalence, annual mortality, and geographic disease distribution from population-based data sources. Arthritis Rheum 1996;39:87-92.
8. Cotch MF, Hoffman GS. The prevalence, epidemiology and cost of hospitalizations for vasculitis in New York State: 1986 to 1990 [abstract]. Arthritis Rheum 1995;38 Suppl 9:S225.
9. Anderson G, Coles ET, Crane M, Douglas AC, Gibbs AR, Geddes DM, et al. Wegener's granuloma: a series of 265 British cases seen between 1975 and 1985. A report by a sub-committee of the British Thoracic Society Research Committee. QJM 1992;83:427-43.
10. Guyatt GH, Kirshner B, Jaeschke R. Measuring health status: what are the necessary measurement properties? J Clin Epidemiol 1992;45:1341-5.
11. Guyatt GH, Feeny DH, Patrick DL. Measuring health-related quality of life. Ann Intern Med 1993;118:622-9.